Baker Tilly, a prominent advisory, tax, and assurance firm, has announced a strategic collaboration with Definitive Healthcare to improve fair market value (FMV) and key opinion leader (KOL) compliance processes for life sciences companies. This partnership combines Baker Tilly’s extensive life sciences expertise Definitive Healthcare’s robust KOL dataset, which includes over 7.4 million profiles enriched with global data elements, will enhance Baker Tilly’s kolNOW platform. The integration is designed to deliver comprehensive and actionable insights, improving compliance and regulatory navigation for life sciences firms. Baker Tilly’s rigorous controls around healthcare professional engagement and its global presence further underscore its commitment to advancing industry standards. This collaboration is set to significantly impact the life sciences sector by providing enhanced data analytics and compliance solutions.
Baker Tilly Partners with Definitive Healthcare for Enhanced Life Sciences Compliance
with Definitive Healthcare’s Monocl ExpertData, which integrates expert data into internal systems. The aim is to establish a new standard in compliance, leveraging Baker Tilly’s transparent FMV methodologies and KOL management practices to address industry challenges, including the shortage of specialized expertise.